Have your own idea? Try our Stock Screener
Pakistani (KSE) Pharma Industry Analysis
UpdatedMar 14, 2025
DataAggregated Company Financials
Companies11
- 7D1.1%
- 3M-4.4%
- 1Y158.6%
- YTD-6.2%
Over the last 7 days, the Pharma industry has risen 1.1%, driven by gains in Searle and BF Biosciences of 3.8% and 10%, respectively. This takes the industry's 12 month performance to a gain of 159%.
Industry Valuation and Performance
Has the Pakistani Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 14 Mar 2025 | PK₨470.3b | PK₨266.0b | PK₨20.9b | 25.6x | 22.5x | 1.8x |
| Sun, 09 Feb 2025 | PK₨489.4b | PK₨257.1b | PK₨19.2b | 23.6x | 25.5x | 1.9x |
| Tue, 07 Jan 2025 | PK₨479.2b | PK₨257.1b | PK₨19.2b | 23x | 25x | 1.9x |
| Thu, 05 Dec 2024 | PK₨458.4b | PK₨257.0b | PK₨19.0b | 22x | 24.1x | 1.8x |
| Sat, 02 Nov 2024 | PK₨343.5b | PK₨254.8b | PK₨18.9b | 17.8x | 18.2x | 1.3x |
| Mon, 30 Sep 2024 | PK₨278.7b | PK₨251.2b | PK₨12.3b | 16.8x | 22.6x | 1.1x |
| Wed, 28 Aug 2024 | PK₨262.5b | PK₨246.7b | PK₨10.8b | 17.9x | 24.4x | 1.1x |
| Fri, 26 Jul 2024 | PK₨240.8b | PK₨243.6b | PK₨8.3b | 16.9x | 29.1x | 1x |
| Sun, 23 Jun 2024 | PK₨243.1b | PK₨243.6b | PK₨8.3b | 16.3x | 29.4x | 1x |
| Tue, 21 May 2024 | PK₨225.6b | PK₨234.6b | PK₨9.0b | 27.2x | 24.9x | 1x |
| Thu, 18 Apr 2024 | PK₨185.5b | PK₨228.8b | PK₨6.6b | 36.1x | 28.2x | 0.8x |
| Sat, 16 Mar 2024 | PK₨167.6b | PK₨224.1b | PK₨6.3b | 20.8x | 26.5x | 0.7x |
| Mon, 12 Feb 2024 | PK₨163.9b | PK₨221.2b | PK₨6.3b | 20.3x | 26.1x | 0.7x |
| Wed, 10 Jan 2024 | PK₨169.7b | PK₨221.2b | PK₨6.3b | 20.3x | 27x | 0.8x |
| Fri, 08 Dec 2023 | PK₨179.9b | PK₨219.1b | PK₨6.1b | 23.3x | 29.3x | 0.8x |
| Sun, 05 Nov 2023 | PK₨149.1b | PK₨218.2b | PK₨6.2b | 20x | 24.1x | 0.7x |
| Tue, 03 Oct 2023 | PK₨122.7b | PK₨209.9b | PK₨7.3b | 11.8x | 16.8x | 0.6x |
| Thu, 31 Aug 2023 | PK₨128.4b | PK₨208.6b | PK₨8.3b | 12.2x | 15.4x | 0.6x |
| Sat, 29 Jul 2023 | PK₨140.4b | PK₨205.6b | PK₨8.7b | 12.8x | 16.1x | 0.7x |
| Mon, 26 Jun 2023 | PK₨124.8b | PK₨205.6b | PK₨8.7b | 11.7x | 14.3x | 0.6x |
| Wed, 24 May 2023 | PK₨137.4b | PK₨199.5b | PK₨11.6b | 12.5x | 11.8x | 0.7x |
| Fri, 21 Apr 2023 | PK₨137.1b | PK₨194.2b | PK₨13.8b | 9.4x | 9.9x | 0.7x |
| Sun, 19 Mar 2023 | PK₨145.5b | PK₨191.5b | PK₨15.1b | 9.7x | 9.7x | 0.8x |
| Tue, 14 Feb 2023 | PK₨150.3b | PK₨189.4b | PK₨15.2b | 10.1x | 9.9x | 0.8x |
| Thu, 12 Jan 2023 | PK₨152.8b | PK₨189.4b | PK₨15.2b | 10x | 10x | 0.8x |
| Sat, 10 Dec 2022 | PK₨169.5b | PK₨188.7b | PK₨15.0b | 11.3x | 11.3x | 0.9x |
| Mon, 07 Nov 2022 | PK₨188.7b | PK₨187.0b | PK₨15.5b | 12.4x | 12.1x | 1x |
| Wed, 05 Oct 2022 | PK₨196.4b | PK₨179.3b | PK₨18.4b | 10.5x | 10.7x | 1.1x |
| Fri, 02 Sep 2022 | PK₨206.3b | PK₨171.3b | PK₨20.0b | 12x | 10.3x | 1.2x |
| Sun, 31 Jul 2022 | PK₨205.5b | PK₨169.3b | PK₨21.5b | 10.3x | 9.5x | 1.2x |
| Tue, 28 Jun 2022 | PK₨210.5b | PK₨167.9b | PK₨21.4b | 9.5x | 9.8x | 1.3x |
| Thu, 26 May 2022 | PK₨204.4b | PK₨163.7b | PK₨21.2b | 8.8x | 9.6x | 1.2x |
| Sat, 23 Apr 2022 | PK₨221.8b | PK₨161.9b | PK₨21.1b | 10x | 10.5x | 1.4x |
| Mon, 21 Mar 2022 | PK₨221.4b | PK₨160.8b | PK₨19.7b | 11x | 11.2x | 1.4x |
Price to Earnings Ratio
11.2x
Current Industry PE
- Investors are optimistic on the Pakistani Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 22.5x which is higher than its 3-year average PE of 18.2x.
- The 3-year average PS ratio of 1.0x is lower than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 18% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare industry?
| PK Market | 0.63% | |
| Healthcare | 1.78% | |
| Pharma | 1.11% | |
| Pharma | 1.11% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BFBIO BF Biosciences | PK₨183.55 | 6.7% +PK₨1.0b | n/a | PE37.9x | |
| HPL Hoechst Pakistan | PK₨3.19k | 2.6% +PK₨773.4m | 153.4% | PE16.6x | |
| CPHL Citi Pharma | PK₨91.79 | 2.5% +PK₨511.8m | 288.6% | PE25.5x | |
| SEARL Searle | PK₨95.82 | 0.9% +PK₨439.9m | 81.1% | PE32.9x | |
| ABOT Abbott Laboratories (Pakistan) | PK₨1.06k | 0.3% +PK₨329.9m | 131.8% | PE19.8x |